Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women

The Women’s Health Initiative trial found a modestly increased risk of invasive breast cancer with daily 0.625-mg conjugated equine estrogens plus 2.5-mg medroxyprogesterone acetate, with most evidence among women who had previously received postmenopausal hormone therapy. In comparison, observation...

Full description

Saved in:
Bibliographic Details
Main Authors: Prentice, Ross L., Chlebowski, Rowan T., Stefanick, Marcia L., Manson, JoAnn E., Pettinger, Mary, Hendrix, Susan L., Hubbell, F. Allan, Kooperberg, Charles, Kuller, Lewis H., Lane, Dorothy S., McTiernan, Anne, O’Sullivan, Mary Jo, Rossouw, Jacques E., Anderson, Garnet L.
Format: Artigo
Language:Inglês
Published: 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670848/
https://ncbi.nlm.nih.gov/pubmed/18372396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwn044
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items